Novozymes was a global biotechnology company headquartered in Denmark, and a world leader in the research, development, and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients. Formed in 2000 as a spin-off from Novo Nordisk, Novozymes focused on creating sustainable solutions across a wide range of industries, including agriculture, food and beverages, household care, bioenergy, and animal health. Their innovative approach aimed to improve industrial performance while reducing environmental impact. On January 29, 2024, Novozymes merged with Chr. Hansen to form Novonesis, a leading global biosolutions partner.
Served as the primary center for corporate management, global research and development, strategic planning, and administrative functions for Novozymes' worldwide operations.
The Bagsvaerd campus is known for its modern research laboratories, pilot plants, and sustainable design elements, reflecting the company's commitment to innovation and environmental responsibility. It housed state-of-the-art fermentation and enzyme production research facilities.
The work culture at Novozymes' HQ was characterized by a strong emphasis on science, innovation, sustainability, and collaboration. It fostered an international environment with a focus on research-driven solutions and employee well-being.
The Bagsvaerd headquarters was pivotal in establishing Novozymes as a global leader in biotechnology, driving innovation in enzyme and microbial technologies that have impacted numerous industries worldwide.
Prior to its merger into Novonesis, Novozymes operated a comprehensive global network supporting its worldwide business. This included research and development centers in key innovation hubs, numerous application centers tailoring solutions to local market needs, strategically located manufacturing facilities ensuring reliable supply, and sales offices providing customer support across all major regions. This global footprint enabled Novozymes to serve diverse industries including agriculture, bioenergy, food & beverages, home care, and animal health on a worldwide scale.
Krogshoejvej 36
Bagsvaerd
Capital Region
Denmark
Address: 77 Perry Chapel Church Rd, Franklinton, NC 27525, USA
Served as a key manufacturing and innovation hub for the Americas, supporting regional customers and contributing to global supply chains.
Address: No. 100, 11th Avenue, TEDA, Tianjin, 300457, P.R.China
Supported Novozymes' growth in the rapidly expanding Asian markets, tailoring solutions to local needs and manufacturing capabilities.
Address: Rua Professor Duílio Calderari, 1750 - Chapada, Araucária - PR, 83707-000, Brazil
Focused on leveraging Brazil's strong bioenergy and agricultural sectors, providing localized production and technical support.
Address: Sy.No. 197/P & 28/P, The Athenaeum, Central B Wing, 8th Floor, Near Spice Garden Restaurant, Kundalahalli, Bangalore – 560037, India
Catered to the specific needs of the Indian subcontinent, fostering innovation and market development in a key growth region.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Novozymes' leadership includes:
Novozymes has been backed by several prominent investors over the years, including:
Executive movements at Novozymes in the 12 months prior to its January 2024 merger into Novonesis included a key hire and a departure within its executive team. The period was overwhelmingly characterized by the planned merger with Chr. Hansen, with key Novozymes leaders subsequently appointed to executive positions in the new company, Novonesis.
Discover the tools Novozymes uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Prior to its merger into Novonesis, Novozymes commonly used an email format based on employee initials. This typically consisted of a 3 or 4 character code derived from the employee's name. Following the merger, email addresses are transitioning to Novonesis standards.
[initial_code]@novozymes.com (typically 3-4 character code derived from employee's name)
Format
exyz@novozymes.com (example for an employee with a 4-letter code like EXYZ)
Example
70%
Success rate
Novonesis Investor Relations • January 29, 2024
Novozymes A/S and Chr. Hansen Holding A/S successfully completed their merger, officially forming Novonesis. The new company combines the strengths of both legacy organizations to become a leading global biosolutions partner....more
Novozymes Investor Relations (Archived on Novonesis) • November 9, 2023
Novozymes announced its financial results for the third quarter of 2023, highlighting organic sales growth and continued progress on the planned merger with Chr. Hansen, including obtaining key regulatory approvals....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Novozymes, are just a search away.